Cargando…

Breast Cancer Recurrence Risk Assessment: Is Non-Invasive Monitoring an Option?

BACKGROUND: Metastatic breast cancer (MBC) represents a life-threatening disease with a median survival time of 18–24 months that often can only be treated palliatively. The majority of women suffering from MBC are those who had been previously diagnosed with locally advanced disease and subsequentl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schunkert, Elisa M., Zhao, Wanzhou, Zänker, Kurt
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6945973/ https://www.ncbi.nlm.nih.gov/pubmed/31988964 http://dx.doi.org/10.1159/000492929

Ejemplares similares

Risk Factors of the Invasive Breast Cancer Locoregional Recurrence
por: Liubota, R. V., et al.
Publicado: (2015)

Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
por: Sumi, Natalia J., et al.
Publicado: (2014)

Perineural invasion as a risk factor for locoregional recurrence of invasive breast cancer
por: Narayan, Priyanka, et al.
Publicado: (2021)

Invasive and noninvasive cardiovascular monitoring options for cardiac surgery
por: Recco, Dominic P., et al.
Publicado: (2022)

Hybrid clone cells derived from human breast epithelial cells and human breast cancer cells exhibit properties of cancer stem/initiating cells
por: Gauck, Daria, et al.
Publicado: (2017)

Fusion of CCL21 Non-Migratory Active Breast Epithelial and Breast Cancer Cells Give Rise to CCL21 Migratory Active Tumor Hybrid Cell Lines
por: Berndt, Benjamin, et al.
Publicado: (2013)

Non-invasive Serological Monitoring for Crohn’s Disease Postoperative Recurrence
por: Hamilton, Amy L, et al.
Publicado: (2022)

Hybrid Cells Derived from Human Breast Cancer Cells and Human Breast Epithelial Cells Exhibit Differential TLR4 and TLR9 Signaling
por: Tosun, Songül, et al.
Publicado: (2016)

Assessment of Xpert Bladder Cancer Monitor test performance for the detection of recurrence during non-muscle invasive bladder cancer follow-up
por: Cancel-Tassin, G., et al.
Publicado: (2021)

Personalized Cancer Care: Risk Prediction, Early Diagnosis, Progression, and Therapy
por: Zänker, Kurt S., et al.
Publicado: (2016)

EORTC risk tables – their usefulness in the assessment of recurrence and progression risk in non–muscle–invasive bladder cancer in Polish patients
por: Borkowska, Edyta M., et al.
Publicado: (2013)

Monitoring for Breast Cancer Recurrence Following Goldilocks Breast Reconstruction
por: Ghanouni, Arian, et al.
Publicado: (2023)

High-Risk Non-Muscle-Invasive Bladder Cancer—Therapy Options During Intravesical BCG Shortage
por: Veeratterapillay, Rajan, et al.
Publicado: (2016)

Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options
por: McAnena, Peter F., et al.
Publicado: (2018)

Reversed Abdominoplasty in Aggressive Locally Advanced Breast Cancer Defect: A Safe Option for High Recurrence Risk Patients
por: Ganandran, Thevarasan, et al.
Publicado: (2022)

Current treatment options for recurrent nasopharyngeal cancer
por: Suárez, Carlos, et al.
Publicado: (2010)

Comparison of hybrid clones derived from human breast epithelial cells and three different cancer cell lines regarding in vitro cancer stem/ initiating cell properties
por: Fahlbusch, Sera Selina, et al.
Publicado: (2020)

Matrix metalloproteinase-9 (MMP9) is involved in the TNF-α-induced fusion of human M13SV1-Cre breast epithelial cells and human MDA-MB-435-pFDR1 cancer cells
por: Weiler, Julian, et al.
Publicado: (2018)

Non-invasive treatment options for focal cortical dysplasia
por: WANG, TING-TING, et al.
Publicado: (2016)

Treatment options in non-muscle-invasive bladder cancer after BCG failure
por: Brooks, Nathan A., et al.
Publicado: (2015)

Non-Invasive and Real-Time Monitoring of the Breast Cancer Metastasis Degree via Metabolomics
por: Zhu, Wanfang, et al.
Publicado: (2022)

Correction to: Breast cancer subtype discordance: impact on post-recurrence survival and potential treatment options
por: McAnena, Peter F., et al.
Publicado: (2018)

Local and Regional Breast Cancer Recurrences: Salvage Therapy Options in the New Era of Molecular Subtypes
por: Belkacemi, Yazid, et al.
Publicado: (2018)

Xpert Bladder Cancer Monitor for the Early Detection of Non-Muscle Invasive Bladder Cancer Recurrences: Could Cystoscopy Be Substituted?
por: Lozano, Fernando, et al.
Publicado: (2023)

Recurrent Intussusception: Management Options
por: Mirza, Bilal
Publicado: (2011)

Hybrid cells derived from breast epithelial cell/breast cancer cell fusion events show a differential RAF-AKT crosstalk
por: Özel, Cem, et al.
Publicado: (2012)

Akt and phospholipase Cγ are involved in the regulation of growth and migration of MDA-MB-468 breast cancer and SW480 colon cancer cells when cultured with diabetogenic levels of glucose and insulin
por: Tomas, Nicola M, et al.
Publicado: (2012)

Emerging Treatment Options for Advanced or Recurrent Endometrial Cancer
por: Halla, Kimberly
Publicado: (2022)

Recurrent Endometrial Cancer: Local and Systemic Treatment Options
por: Rütten, Heidi, et al.
Publicado: (2021)

Recurrent Differentiated Thyroid Cancer: The Current Treatment Options
por: Coca-Pelaz, Andrés, et al.
Publicado: (2023)

The association of BMI with risk of recurrence and progression in patients with non-muscle-invasive bladder cancer
por: Vrieling, Alina
Publicado: (2018)

Non-invasive optical spectroscopic monitoring of breast development during puberty
por: Lilge, Lothar, et al.
Publicado: (2017)

Completion pneumonectomy and chemoradiotherapy as treatment options in local recurrence of non-small-cell lung cancer
por: Kasprzyk, Mariusz, et al.
Publicado: (2015)

Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular Carcinoma
por: Nunes, Raquel, et al.
Publicado: (2021)

The usefulness of CanAssist Breast over Ki67 in breast cancer recurrence risk assessment
por: Eshwaraiah, Mallikarjuna Siraganahalli, et al.
Publicado: (2023)

Current management options for recurrent adrenocortical carcinoma
por: Glover, Anthony R, et al.
Publicado: (2013)

Luminal and basal-like breast cancer cells show increased migration induced by hypoxia, mediated by an autocrine mechanism
por: Voss, Melanie J, et al.
Publicado: (2011)

Luminosity Monitor Options for TESLA
por: Napoly, O, et al.
Publicado: (1998)

Risk assessment model for invasive breast cancer in Hong Kong women
por: Wang, Feng, et al.
Publicado: (2016)

Statins and risk of breast cancer recurrence
por: Sakellakis, Minas, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4q4vlq25lud6062r1i52rbog4c